Paydirt
RVMD
Ticker

Revolution Medicines, Inc.

RVMD · Healthcare · Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers

Revolution Medicines, Inc. (RVMD), in the Healthcare sector, has 54 disclosed filings on Paydirt over the trailing twelve months from 12 corporate insiders: 0 purchases and 54 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Oct 26 and filed Oct 28. The most active filer was Mark A Goldsmith with 11 filings. Data as of Nov 7 2026.

Add to watchlist
Filings, ttm
54
0 buys · 54 sells · 1 late
Traders, ttm
12
12 insiders
Volume, ttmiDollar value disclosed in the window
$141.8M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Oct 26
Filed Oct 28
ADViAverage daily dollar volume
$548.2M
market data
Share price · 12M
$191 (+205.0%)
$221$142$62.73Nov 10 2025May 7Oct 30

Adjusted for splits and dividends.

Volume by month
$60.0M$30.0M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · buys $60.0MDec 2024 · sells $1.1MMar 2025 · sells $706KJun 2025 · sells $848KSep 2025 · sells $7.1MOct 2025 · sells $2.9MNov 2025 · sells $11.5MDec 2025 · sells $2.4MJan 2026 · sells $8.6MMar 2026 · sells $9.9MApr 2026 · sells $18.4MMay 2026 · sells $415KJun 2026 · sells $23.4MJul 2026 · sells $919KAug 2026 · sells $29.6MSep 2026 · sells $46.4MOct 2026 · sells $1.6M
Buys $60.0M Sells $165.8M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
MG Mark A Goldsmith See Remarks 16 filings · 0 buys, 16 sales SK Stephen Michael Kelsey See Remarks 12 filings · 0 buys, 12 sales JA Jack Anders Chief Financial Officer 11 filings · 0 buys, 11 sales JC Jeff Cislini SVP & General Counsel 11 filings · 0 buys, 11 sales MH Margaret A Horn Chief Operating Officer 10 filings · 0 buys, 10 sales AM Anthony Mancini See Remarks 9 filings · 0 buys, 9 sales LK Lorence H. Kim Director 2 filings · 0 buys, 2 sales EA Elizabeth M Anderson Director 1 filing · 0 buys, 1 sale
All 13 filers SP Sushil Patel Director 1 filing · 0 buys, 1 sale AS Alan B. Sandler Chief Development Officer 1 filing · 0 buys, 1 sale TS Thilo Schroeder Director 1 filing · 1 buy, 0 sales XW Xiaolin Wang See Remarks 1 filing · 0 buys, 1 sale LW Lin Wei Chief Medical Officer 1 filing · 0 buys, 1 sale
Recent filings
Anthony ManciniSALE See Remarks $432K
2,310 sh × $186.99
Exec Oct 26
Filed Oct 28 · 6:00 PM ET
Alan B. SandlerSALE Chief Development Officer $1.2M
6,008 sh across 4 lots
Exec Sep 29
Filed Oct 1 · 6:00 PM ET
Jeff CisliniSALE SVP & General Counsel $159K
765 sh × $207.32
Exec Sep 25
Filed Sep 29 · 6:00 PM ET
Anthony ManciniSALE See Remarks $743K
3,708 sh across 2 lots
Exec Sep 24
Filed Sep 28 · 6:00 PM ET
Elizabeth M AndersonSALE Director $1.9M
10,043 sh across 4 lots
Exec Sep 22
Filed Sep 24 · 6:00 PM ET
Anthony ManciniSALE See Remarks $347K
1,764 sh × $196.94
Exec Sep 18
Filed Sep 22 · 6:00 PM ET
Anthony ManciniSALE See Remarks $348K
1,747 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:05 PM ET
Stephen Michael KelseySALE See Remarks $1.1M
5,484 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:04 PM ET
Margaret A HornSALE Chief Operating Officer $975K
4,891 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:03 PM ET
Mark A GoldsmithSALE See Remarks $2.7M
13,775 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:02 PM ET
Jeff CisliniSALE SVP & General Counsel $660K
3,314 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:01 PM ET
Jack AndersSALE Chief Financial Officer $796K
3,992 sh × $199.30
Exec Sep 16
Filed Sep 18 · 6:00 PM ET
Stephen Michael KelseySALE See Remarks $18.7M
92,531 sh across 8 lots
Exec Sep 11
Filed Sep 15 · 6:00 PM ET
Anthony ManciniSALE See Remarks $3.1M
15,148 sh across 4 lots
Exec Sep 10
Filed Sep 14 · 6:03 PM ET
Lorence H. KimSALE Director $3.5M
16,719 sh across 6 lots
Exec Sep 8
Filed Sep 10 · 5:52 PM ET
Lorence H. KimSALE Director $11.3M
55,700 sh across 6 lots
Exec Aug 31
Filed Sep 2 · 4:30 PM ET
Jeff CisliniSALE General Counsel $11.9M
56,894 sh across 6 lots
Exec Aug 21
Filed Aug 25 · 4:06 PM ET
Mark A GoldsmithSALE See Remarks $17.7M
84,644 sh across 10 lots
Exec Aug 21
Filed Aug 25 · 4:06 PM ET
Sushil PatelSALE Director $919K
4,880 sh across 6 lots
Exec Jun 29
Filed Jul 1 · 6:25 PM ET
Jack AndersSALE Chief Financial Officer $3.3M
19,700 sh across 3 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET
Stephen Michael KelseySALE See Remarks $652K
4,175 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET
Jack AndersSALE Chief Financial Officer $425K
2,722 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET
Jeff CisliniSALE General Counsel $337K
2,157 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET
Mark A GoldsmithSALE See Remarks $1.6M
10,020 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET
Anthony ManciniSALE See Remarks $720K
4,615 sh × $156.12
Exec Jun 16
Filed Jun 18 · 5:30 PM ET